- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.95 Å
- Oligo State
- homo-tetramer
- Ligands
- 2 x NAG- FUC: alpha-L-fucopyranose-(1-3)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- 1 x NAG- NAG- BMA- XYP- MAN- MAN- FUC: beta-D-xylopyranose-(1-2)-[alpha-D-mannopyranose-(1-3)][alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-3)]2-acetamido-2-deoxy-beta-D-glucopyranose(Non-functional Binders)
- 4 x CA: CALCIUM ION(Non-covalent)(Non-functional Binders)
- 4 x MN: MANGANESE (II) ION(Non-functional Binders)(Non-covalent)
MN.5: 4 residues within 4Å:- Chain A: E.125, D.127, D.134, H.139
6 PLIP interactions:4 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:E.125, A:D.127, A:D.134, A:H.139, H2O.1, H2O.2
MN.10: 4 residues within 4Å:- Chain B: E.125, D.127, D.134, H.139
6 PLIP interactions:4 interactions with chain B, 2 Ligand-Water interactions- Metal complexes: B:E.125, B:D.127, B:D.134, B:H.139, H2O.9, H2O.10
MN.14: 4 residues within 4Å:- Chain C: E.125, D.127, D.134, H.139
6 PLIP interactions:4 interactions with chain C, 2 Ligand-Water interactions- Metal complexes: C:E.125, C:D.127, C:D.134, C:H.139, H2O.16, H2O.16
MN.19: 4 residues within 4Å:- Chain D: E.125, D.127, D.134, H.139
6 PLIP interactions:4 interactions with chain D, 2 Ligand-Water interactions- Metal complexes: D:E.125, D:D.127, D:D.134, D:H.139, H2O.20, H2O.21
- 6 x ACT: ACETATE ION(Non-covalent)(Non-functional Binders)
ACT.6: 2 residues within 4Å:- Chain A: F.129
- Ligands: 6Y2.7
2 PLIP interactions:2 interactions with chain A- Water bridges: A:N.131, A:S.132
ACT.11: 5 residues within 4Å:- Chain B: R.150, V.195, D.196, Q.199, I.200
4 PLIP interactions:4 interactions with chain B- Hydrophobic interactions: B:D.196, B:Q.199
- Hydrogen bonds: B:D.196
- Salt bridges: B:R.150
ACT.15: 3 residues within 4Å:- Chain C: N.131, S.132
- Ligands: 6Y2.17
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:S.132, C:S.132
ACT.16: 5 residues within 4Å:- Chain C: R.150, V.195, D.196, Q.199, I.200
4 PLIP interactions:4 interactions with chain C- Hydrophobic interactions: C:D.196, C:Q.199
- Hydrogen bonds: C:D.196
- Salt bridges: C:R.150
ACT.20: 3 residues within 4Å:- Chain D: N.131, S.132
- Ligands: 6Y2.22
4 PLIP interactions:4 interactions with chain D- Hydrogen bonds: D:N.131, D:S.132, D:S.132
- Water bridges: D:S.132
ACT.21: 4 residues within 4Å:- Chain D: R.150, V.195, D.196, I.200
3 PLIP interactions:3 interactions with chain D- Hydrophobic interactions: D:D.196
- Hydrogen bonds: D:D.196
- Salt bridges: D:R.150
- 4 x 6Y2: ~{N}-[(2~{S},3~{R},4~{R},5~{R},6~{R})-2-[(2~{R},3~{S},4~{R},5~{R},6~{S})-5-acetamido-2-(hydroxymethyl)-6-(4-nitrophenoxy)-4-oxidanyl-oxan-3-yl]oxy-6-(hydroxymethyl)-4,5-bis(oxidanyl)oxan-3-yl]ethanamide(Post Translational Modification)(Non-functional Binders)
6Y2.7: 10 residues within 4Å:- Chain A: D.87, G.104, G.105, F.129, N.131, G.214, L.215, S.216, H.219
- Ligands: ACT.6
11 PLIP interactions:11 interactions with chain A- Hydrogen bonds: A:D.87, A:G.105, A:N.131, A:N.131, A:L.215, A:L.215, A:S.216, A:H.219
- Water bridges: A:L.106, A:S.216, A:S.216
6Y2.12: 9 residues within 4Å:- Chain B: D.87, G.104, G.105, F.129, N.131, G.214, L.215, S.216, H.219
8 PLIP interactions:8 interactions with chain B- Hydrogen bonds: B:D.87, B:G.105, B:N.131, B:N.131, B:L.215, B:L.215, B:S.216, B:S.216
6Y2.17: 10 residues within 4Å:- Chain C: D.87, G.104, G.105, F.129, N.131, G.214, L.215, S.216, H.219
- Ligands: ACT.15
7 PLIP interactions:7 interactions with chain C- Hydrogen bonds: C:D.87, C:G.105, C:N.131, C:N.131, C:L.215, C:S.216, C:H.219
6Y2.22: 12 residues within 4Å:- Chain D: D.87, P.103, G.104, G.105, F.129, N.131, W.133, G.214, L.215, S.216, H.219
- Ligands: ACT.20
10 PLIP interactions:10 interactions with chain D- Hydrophobic interactions: D:W.133
- Hydrogen bonds: D:D.87, D:G.105, D:N.131, D:N.131, D:L.215, D:L.215, D:L.215, D:S.216, D:S.216
- 1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)
- Links
- RCSB PDBe PDBj PDBsum CATH PLIP
- Citation
- Haji-Ghassemi, O. et al., Molecular Basis for Recognition of the Cancer Glycobiomarker, LacdiNAc (GalNAc[ beta 14]GlcNAc), by Wisteria floribunda Agglutinin. J.Biol.Chem. (2016)
- Release Date
- 2016-09-14
- Peptides
- Wisteria floribunda agglutinin: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.95 Å
- Oligo State
- homo-tetramer
- Ligands
- 2 x NAG- FUC: alpha-L-fucopyranose-(1-3)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- 1 x NAG- NAG- BMA- XYP- MAN- MAN- FUC: beta-D-xylopyranose-(1-2)-[alpha-D-mannopyranose-(1-3)][alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-3)]2-acetamido-2-deoxy-beta-D-glucopyranose(Non-functional Binders)
- 4 x CA: CALCIUM ION(Non-covalent)(Non-functional Binders)
- 4 x MN: MANGANESE (II) ION(Non-functional Binders)(Non-covalent)
- 6 x ACT: ACETATE ION(Non-covalent)(Non-functional Binders)
- 4 x 6Y2: ~{N}-[(2~{S},3~{R},4~{R},5~{R},6~{R})-2-[(2~{R},3~{S},4~{R},5~{R},6~{S})-5-acetamido-2-(hydroxymethyl)-6-(4-nitrophenoxy)-4-oxidanyl-oxan-3-yl]oxy-6-(hydroxymethyl)-4,5-bis(oxidanyl)oxan-3-yl]ethanamide(Post Translational Modification)(Non-functional Binders)
- 1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)
- Links
- RCSB PDBe PDBj PDBsum CATH PLIP
- Citation
- Haji-Ghassemi, O. et al., Molecular Basis for Recognition of the Cancer Glycobiomarker, LacdiNAc (GalNAc[ beta 14]GlcNAc), by Wisteria floribunda Agglutinin. J.Biol.Chem. (2016)
- Release Date
- 2016-09-14
- Peptides
- Wisteria floribunda agglutinin: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D